AAAAAA

   
Results: 1-16 |
Results: 16
COMBINATION THERAPY IN RECENT-ONSET RHEUMATOID-ARTHRITIS - A RANDOMIZED DOUBLE-BLIND TRIAL OF THE ADDITION OF LOW-DOSE CYCLOSPORINE TO PATIENTS TREATED WITH LOW-DOSE CHLOROQUINE
Authors: VANDENBORNE BEEM LANDEWE RBM THE HSG RIETVELD JH ZWINDERMAN AH BRUYN GAW BREEDVELD FC DIJKMANS BAC
Citation: Beem. Vandenborne et al., COMBINATION THERAPY IN RECENT-ONSET RHEUMATOID-ARTHRITIS - A RANDOMIZED DOUBLE-BLIND TRIAL OF THE ADDITION OF LOW-DOSE CYCLOSPORINE TO PATIENTS TREATED WITH LOW-DOSE CHLOROQUINE, Journal of rheumatology, 25(8), 1998, pp. 1493-1498
CYCLOSPORINE-A THERAPY IN RHEUMATOID-ARTHRITIS - ONLY STRICT APPLICATION OF THE GUIDELINES FOR SAFE USE CAN PREVENT IRREVERSIBLE RENAL-FUNCTION LOSS
Authors: VANDENBORNE BEEM LANDEWE RBM THE HSG BREEDVELD FC DIJKMANS BAC
Citation: Beem. Vandenborne et al., CYCLOSPORINE-A THERAPY IN RHEUMATOID-ARTHRITIS - ONLY STRICT APPLICATION OF THE GUIDELINES FOR SAFE USE CAN PREVENT IRREVERSIBLE RENAL-FUNCTION LOSS, Arthritis and rheumatism, 41(9), 1998, pp. 729-729
DOES LONG-TERM CYCLOSPORINE-A TREATMENT IN RHEUMATOID-ARTHRITIS PROTECT AGAINST CANCER
Authors: VANDENBORNE BEEM LANDEWE RBM BREEDVELD FC MOENS HJB DIJKMANS BAC
Citation: Beem. Vandenborne et al., DOES LONG-TERM CYCLOSPORINE-A TREATMENT IN RHEUMATOID-ARTHRITIS PROTECT AGAINST CANCER, Arthritis and rheumatism, 41(9), 1998, pp. 730-730
NO INCREASED RISK OF MALIGNANCIES AND MORTALITY IN CYCLOSPORINE A-TREATED PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: VANDENBORNE BEEM LANDEWE RBM HOUKES I SCHILD F VANDERHEYDEN PCW HAZES JMW VANDENBROUCKE JP ZWINDERMAN AH THE HSG BREEDVELD FC MOENS HJB KLUIN PM DIJKMANS BAC
Citation: Beem. Vandenborne et al., NO INCREASED RISK OF MALIGNANCIES AND MORTALITY IN CYCLOSPORINE A-TREATED PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(11), 1998, pp. 1930-1937
NO INCREASED RISK OF MALIGNANCIES AND MORTALITY IN CYCLOSPORINE-A TREATED RHEUMATOID-ARTHRITIS PATIENTS
Authors: VANDENBORNE BEEM LANDEWE RBM HOUKES I SCHILD F VANDERHEYDEN PCW HAZES JMW VANDENBROUCKE JP ZWINDERMAN AH THE HSG BREEDVELD FC MOENS HJB KLUYN P DIJKMANS BAC
Citation: Beem. Vandenborne et al., NO INCREASED RISK OF MALIGNANCIES AND MORTALITY IN CYCLOSPORINE-A TREATED RHEUMATOID-ARTHRITIS PATIENTS, Arthritis and rheumatism, 40(9), 1997, pp. 985-985
CHLOROQUINE COMBINED WITH CYCLOSPORINE IN RHEUMATOID-ARTHRITIS - MORETHAN THE ADDITION OF 2 DRUGS ALONE
Authors: DIJKMANS BAC VANDENBORNE BEEM LANDEWE RBM MILTENBURG AMM VERWEIJ CL BREEDVELD FC
Citation: Bac. Dijkmans et al., CHLOROQUINE COMBINED WITH CYCLOSPORINE IN RHEUMATOID-ARTHRITIS - MORETHAN THE ADDITION OF 2 DRUGS ALONE, Journal of rheumatology, 23, 1996, pp. 61-63
THE BENEFIT RISK RATIO OF LOW-DOSE CYCLOSPORINE-A IN RHEUMATOID-ARTHRITIS - REPLY
Authors: LANDEWE RBM THE HSG DIJKMANS BAC
Citation: Rbm. Landewe et al., THE BENEFIT RISK RATIO OF LOW-DOSE CYCLOSPORINE-A IN RHEUMATOID-ARTHRITIS - REPLY, Journal of rheumatology, 23(2), 1996, pp. 404-405
LONG-TERM LOW-DOSE CYCLOSPORINE IN PATIENTS WITH RHEUMATOID-ARTHRITIS- RENAL-FUNCTION LOSS WITHOUT STRUCTURAL NEPHROPATHY
Authors: LANDEWE RBM DIJKMANS BAC VANDERWOUDE FJ BREEDVELD FC MIHATSCH MJ BRUIJN JA
Citation: Rbm. Landewe et al., LONG-TERM LOW-DOSE CYCLOSPORINE IN PATIENTS WITH RHEUMATOID-ARTHRITIS- RENAL-FUNCTION LOSS WITHOUT STRUCTURAL NEPHROPATHY, Journal of rheumatology, 23(1), 1996, pp. 61-64
LOW-DOSE CYCLOSPORINE IN EARLY RHEUMATOID-ARTHRITIS - EFFECTIVE AND SAFE AFTER 2 YEARS OF THERAPY WHEN COMPARED WITH CHLOROQUINE
Authors: VANDENBORNE BEEM LANDEWE RBM THE HSG BREEDVELD FC DIJKMANS BAC
Citation: Beem. Vandenborne et al., LOW-DOSE CYCLOSPORINE IN EARLY RHEUMATOID-ARTHRITIS - EFFECTIVE AND SAFE AFTER 2 YEARS OF THERAPY WHEN COMPARED WITH CHLOROQUINE, Scandinavian journal of rheumatology, 25(5), 1996, pp. 307-316
PERSISTENT CD3-CROSS-LINKING DOWN-REGULATES INTERLEUKIN-2 RESPONSIVENESS IN INTERLEUKIN-2-COMPETENT CLONED T-CELLS - THE POSSIBLE INVOLVEMENT OF PROTEIN-KINASE-C
Authors: LANDEWE RBM DIJKMANS BAC VERDONK MJA BREEDVELD FC DAHA MR MILTENBURG AMM
Citation: Rbm. Landewe et al., PERSISTENT CD3-CROSS-LINKING DOWN-REGULATES INTERLEUKIN-2 RESPONSIVENESS IN INTERLEUKIN-2-COMPETENT CLONED T-CELLS - THE POSSIBLE INVOLVEMENT OF PROTEIN-KINASE-C, Scandinavian journal of immunology, 44(1), 1996, pp. 45-53
ANTIMALARIAL DRUG-INDUCED DECREASE IN CREATININE CLEARANCE
Authors: LANDEWE RBM VERGOUWEN MSC THE HSG VANRIJTHOVEN AWAM BREEDVELD FC DIJKMANS BAC
Citation: Rbm. Landewe et al., ANTIMALARIAL DRUG-INDUCED DECREASE IN CREATININE CLEARANCE, Journal of rheumatology, 22(1), 1995, pp. 34-37
RELATIVE BIOAVAILABILITY OF A NEW ORAL FORM OF CYCLOSPORINE-A IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: VANDENBORNE BEEM LANDEWE RBM THE HSG MATTIE H BREEDVELD FC DIJKMANS BAC
Citation: Beem. Vandenborne et al., RELATIVE BIOAVAILABILITY OF A NEW ORAL FORM OF CYCLOSPORINE-A IN PATIENTS WITH RHEUMATOID-ARTHRITIS, British journal of clinical pharmacology, 39(2), 1995, pp. 172-175
CHLOROQUINE INHIBITS T-CELL PROLIFERATION BY INTERFERING WITH IL-2 PRODUCTION AND RESPONSIVENESS
Authors: LANDEWE RBM MILTENBURG AMM VERDONK MJA VERWEIJ CL BREEDVELD FC DAHA MR DIJKMANS BAC
Citation: Rbm. Landewe et al., CHLOROQUINE INHIBITS T-CELL PROLIFERATION BY INTERFERING WITH IL-2 PRODUCTION AND RESPONSIVENESS, Clinical and experimental immunology, 102(1), 1995, pp. 144-151
CYCLOSPORINE IN COMMON CLINICAL-PRACTICE - AN ESTIMATION OF THE BENEFIT RISK RATIO IN PATIENTS WITH RHEUMATOID-ARTHRITIS/
Authors: LANDEWE RBM THE HSG VANRIJTHOVEN AWAM RIETVELD JR BREEDVELD FC DIJKMANS BAC
Citation: Rbm. Landewe et al., CYCLOSPORINE IN COMMON CLINICAL-PRACTICE - AN ESTIMATION OF THE BENEFIT RISK RATIO IN PATIENTS WITH RHEUMATOID-ARTHRITIS/, Journal of rheumatology, 21(9), 1994, pp. 1631-1636
A RANDOMIZED, DOUBLE-BLIND, 24-WEEK CONTROLLED-STUDY OF LOW-DOSE CYCLOSPORINE VERSUS CHLOROQUINE FOR EARLY RHEUMATOID-ARTHRITIS
Authors: LANDEWE RBM THE HSG VANRIJTHOVEN AWAM BREEDVELD FC DIJKMANS BAC
Citation: Rbm. Landewe et al., A RANDOMIZED, DOUBLE-BLIND, 24-WEEK CONTROLLED-STUDY OF LOW-DOSE CYCLOSPORINE VERSUS CHLOROQUINE FOR EARLY RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 37(5), 1994, pp. 637-643
CYCLOSPORINE IN EARLY RHEUMATOID-ARTHRITIS - DELAYED-ONSET OF OPTIMALCLINICAL EFFICACY
Authors: LANDEWE RBM THE HSG VANRIJTHOVEN AWAM BREEDVELD FC DIJKMANS BAC
Citation: Rbm. Landewe et al., CYCLOSPORINE IN EARLY RHEUMATOID-ARTHRITIS - DELAYED-ONSET OF OPTIMALCLINICAL EFFICACY, Arthritis and rheumatism, 36(9), 1993, pp. 190000215-190000215
Risultati: 1-16 |